Prolonged islet allograft survival in diabetic NOD mice by targeting CD45RB and CD154

RD Molano, A Pileggi, T Berney, R Poggioli, E Zahr… - Diabetes, 2003 - Am Diabetes Assoc
Clinical islet transplantation is a successful procedure that can improve the quality of life in
recipients with diabetes. A drawback of the procedure is the need for chronic administration …

Long-term islet graft survival in NOD mice by abrogation of recurrent autoimmunity

Q Shi, D Wang, GA Hadley, AW Bingaman… - Diabetes, 2004 - Am Diabetes Assoc
Islet transplantation has great potential for curing type 1 diabetes; however, long-term islet
survival using conventional immunosuppression remains elusive. We present a novel …

Nondepleting anti-CD4 and soluble interleukin-1 receptor prevent autoimmune destruction of syngeneic islet grafts in diabetic NOD mice1

M Drage, P Zaccone, JM Phillips, F Nicoletti… - …, 2002 - journals.lww.com
Background. Successful islet transplantation in type 1 diabetes requires tolerance induction
of both allo-and autoreactive T-cell responses. Monoclonal antibodies targeting the CD4 …

Prolonged survival of rat islet xenografts in mice after CD45RB monotherapy

L Visser, S Poppema, B de Haan, P Klok… - …, 2004 - journals.lww.com
Background. Pancreatic islet transplantation can correct the disordered glucose metabolism
of type 1 diabetes, but the number of successful transplants has been low because of the …

Resistance to anti‐CD45RB‐induced tolerance in NOD mice: mechanisms involved

DJ Moore, X Huang, MK Lee IV, MM Lian… - Transplant …, 2004 - Wiley Online Library
While great advances have been made in the success of islet transplantation to cure
autoimmune diabetes, this protocol remains limited by our inability to induce donor‐specific …

Prolonged islet graft survival in NOD mice by blockade of the CD40-CD154 pathway of T-cell costimulation

RD Molano, T Berney, H Li, P Cattan, A Pileggi… - Diabetes, 2001 - Am Diabetes Assoc
Allorejection and recurrence of autoimmunity are the major barriers to transplantation of
islets of Langerhans for the cure of type 1 diabetes in humans. CD40-CD154 (CD40 ligand) …

Anti-CD8 Abrogates Effect of Anti-CD4–Mediated Islet Allograft Survival in Rat Model

K Seydel, J Shizuru, D Grossman, A Wu, S Alters… - Diabetes, 1991 - Am Diabetes Assoc
We studied the effects of anti-CD4 treatment of diabetic ACI rats on the induction oftolerance
to allogeneic (Lewis) islet allografts. When given as a 4-day treatment regimen, OX38, a …

Islet allograft rejection in nonobese diabetic mice involves the common γ-chain and CD28/CD154-dependent and-independent mechanisms

G Demirci, TB Strom, XC Li - The Journal of Immunology, 2003 - journals.aai.org
Once nonobese diabetic (NOD) mice become diabetic, they are highly resistant to islet
transplantation. The precise mechanism of such resistance remains largely unknown. In the …

Immunotherapy with nondepleting anti-CD4 monoclonal antibodies but not CD28 antagonists protects islet graft in spontaneously diabetic NOD mice from …

Z Guo, T Wu, N Kirchhof, D Mital, JW Williams… - …, 2001 - journals.lww.com
Background. T-cell activation and the subsequent induction of effector functions require not
only the recognition of antigen peptides bound to MHC molecules by T-cell receptor (TCR) …

INDEFINITE ISLET ALLOGRAFT SURVIVAL IN MICE AFTER A SHORT COURSE OF TREATMENT WITH ANTI-CD45 MONOCLONAL ANTIBODIES1

LA Auersvald, DM Rothstein, SC Oliveira… - …, 1997 - journals.lww.com
Background. Although islet cell transplantation is considered an ideal form of endocrine
replacement for type I diabetes, clinical application in humans is still not feasible. New …